Typhoid Vi polysaccharide protein conjugate vaccine (Lanzhou institute of biological products)

伤寒Vi多糖蛋白结合疫苗（兰州生物制品研究所）

Report date: 2023/03/02 14:02:41

Base Information

Drug NameTyphoid Vi polysaccharide protein conjugate vaccine (Lanzhou institute of biological products)

Drug Alias NameN/A

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTyphoid Fever

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (NDA/BLA)

Highest Status in ChinaPending

Originator CompaniesLanzhou Institute Of Biological Products Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A

Inactive CompaniesLanzhou Institute Of Biological Products Co Ltd

Active IndicationsN/A

Inactive IndicationsTyphoid Fever

Other Information

ATC CodeN/A